Abstract Submission Guidelines

Electronic Submission: All abstracts for the 2023 Annual Meeting must be submitted electronically at https://asv2023.abstractcentral.com/ for processing, evaluation and inclusion in the ASV 2023 Scientific Program & Abstracts. Complete instructions for electronic submission protocols are provided on the abstract web.

Deadline: Deadline for receipt of electronic abstracts is Wednesday, February 1, 2023 at 11:59 pm Eastern Time. Abstracts received after this date will only be considered for poster presentations, and may not be included in the ASV 2023 Scientific Program & Abstracts.


Abstract Authorship: The first author listed in the list of authors on the abstract must be the person who will actually present the talk or poster. You will also list the email address of this first author (first = presenting author) on the submission form and they will receive all email notifications regarding the date, session and time of presentation.

Abstract Sponsors: An abstract sponsor is an ASV Full Member who can attest that an abstract is scientifically sound and ready for presentation. Non ASV members, ASV student members, and ASV associate members will need to provide the name and email of their sponsors when submitting their abstract. If you are a Full ASV member, you can list yourself on the submission form. Sponsors’ membership dues must be up to date for 2023. If you cannot identify a Full ASV member to sponsor your abstract, contact asv@asv.org.

Withdrawal: Because withdrawal of an abstract greatly disrupts the continuity of the program, do not request a workshop (oral) presentation unless you are certain that you or a co-author will present the paper at the meeting. Every attempt will be made to honor your presentation preference. However, because of the large number of abstracts, not all oral presentations can be accommodated.

If an emergency arises and you must withdraw your abstract (and no co-author is able to make the presentation in your place), you must immediately notify the ASV Office via email at asv@asv.org or by telephone at 734-764-9686.


Word Count: Maximum number of words for the abstract text: 300.

Abstract Title: The title should be concise and informative. Avoid superfluous words such as "preliminary studies on" etc.

Abstract Content: The abstract should educate the reader by clearly stating the originality of the work and its specific conclusions. It is NOT appropriate to state: "The results will be discussed.” All abstracts will be reviewed by the Program Committee but will not be edited. Carefully proofread your abstract for errors.

Tables and Figures: These items are permitted in the abstract.

Topics & Themes: During abstract submission, you will be asked to select 2 or more topics that best match your presentation theme (minimum of 2; maximum of 3 topics). Topics can be chosen from either or both of the lists below. These topic choices will be used to help place abstracts in the most appropriate sessions (choice 1), and organize the talks within sessions thematically (choices 2 and 3).

Virus Families

  • Adeno-, Papilloma-, & Polyoma
  • Arenaviruses
  • Arthropod-borne/Arboviruses
  • Bacteriophages & Archaeal viruses
  • Bornaviruses
  • Bunyaviruses
  • Calici- & Astroviruses
  • Coronaviruses & Arteriviruses
  • Filoviruses
  • Flaviviruses
  • Fungal & Algal viruses
  • Hepatitis Viruses
  • Herpesviruses
  • Invertebrate Viruses
  • Orthomyxoviruses
  • Paramyxoviruses & Pneumoviruses
  • Parvo- & Circaviruses
  • Picornaviruses
  • Plant Viruses
  • Poxviruses
  • Reoviruses & Birnaviruses
  • Retroviruses
  • Rhabdoviruses
  • Rotaviruses
  • Togaviruses


  • Antigen Processing & Presentation
  • Antiviral Therapies
  • Careers Workshop Only
  • Chronic, Latent & Persistent Infections
  • Effector Function & Memory
  • Emerging Viruses
  • Epidemiology & Public Health
  • Epigenetics
  • Evolution, Ecology, & Reservoirs
  • Innate Immune Effector Functions
  • Innate Immune Sensing
  • Interference with Host Defense
  • Non-coding RNAs
  • Novel Methodology & Technology
  • Oncolytics, Gene Therapy & Viral Vectors
  • Pathogenesis
  • Physiological Barriers to Infection
  • Polymicrobial or Multi-virus Interactions
  • Receptors, Attachment & Entry
  • Replication & Gene Expression
  • Reverse Transcription & Integration
  • Signal Transduction
  • Single Cell Virology
  • Structure
  • Systems Biology & Metabolism
  • Trafficking, Assembly, Egress, & Transmission
  • Transformation & Oncogenesis
  • Vaccines
  • Virology Education
  • Virus Discovery
  • Virus-triggered Death Pathways


Katherine R. Spindler
University of Michigan Medical School
Department of Microbiology and Immunology
1150 West Medical Center Drive, 5635 Med Sci II
Ann Arbor, MI 48109-5620
Telephone: 734-764-9686
Email: krspin@umich.edu

Andréa Garcia
Administrator to the Secretary-Treasurer; Email: asv@asv.org

Photo Credit Gallery


Kevin J. Sokoloski
Associate Professor
Department of Microbiology and Immunology
University of Louisville, School of Medicine
Tel: 734-764-9686


ASV 2024

June 24 - 28, 2024

43rd Annual Meeting
The Ohio State University
Greater Columbus Convention Center
Columbus, Ohio

Scroll to Top